The Travelers Companies
- Market cap
- 75.21B
- P/E (TTM)i
- 9.69
- P/Bi
- 2.27
- EPSi
- 27.43
- Div yieldi
- 1.26%
- 52W posi
- 75%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 90.16% -0.03pp
- Institutions
- 2,135 -6
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 10 buys · 39 sells
| Name | Role | Stake |
|---|---|---|
| Alan Schnitzer | Chairperson & CEO | 0.15% |
| William Heyman | Vice Chairperson | 0.13% |
| Maria Olivo | Executive VP of Strategic Development & President of International | 0.06% |
| Daniel Yin | Executive VP & Co-Chief Investment Officer | 0.03% |
| Avrohom Kess | Vice Chairman & Chief Legal Officer for Travelers | 0.02% |
| Michael Klein | Executive VP & President of Personal Insurance | 0.02% |
| David Rowland | Executive VP & Co-Chief Investment Officer | 0.02% |
| Daniel Frey | Chief Financial Officer | 0.01% |
| Andy Bessette | Executive Vice President | 0.01% |
| Gregory Toczydlowski | Executive VP & President of Business Insurance | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Elizabeth Beshel E. Robinson | Independent Director | Other Acquisition | +122 | $356.51 |
| 2026-09-29 | Anthony Jabbour | Director | Other Acquisition | +65 | $356.51 |
| 2026-09-29 | Russell Golden | Independent Director | Other Acquisition | +129 | $356.51 |
| 2026-08-27 | Maria Olivo | Executive VP of Strategic Development & President of International | Open Market Disposition | -6,000 | $369.86 |
| 2026-08-13 | Anthony Jabbour | Director | Other Acquisition | +446 | $370.36 |
| 2026-08-04 | Anthony Jabbour | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-07-27 | William Heyman | Vice Chairperson | Intent to Sell (Form 144) | -2,344 | $398.00 |
| 2026-07-26 | William Heyman | Vice Chairperson | Intent to Sell (Form 144) | -3,572 | $390.50 |
| 2026-07-23 | William Heyman | Vice Chairperson | Intent to Sell (Form 144) | -5,206 | $380.00 |
| 2026-07-23 | Daniel Yin | Executive VP & Co-Chief Investment Officer | Derivative Exercise and Sale | -7,153 | $140.85–387.00 |
| 2026-07-23 | Diane Kurtzman | Executive Vice President | Derivative Exercise and Sale | -4,164 | $132.58–386.71 |
| 2026-07-22 | Laurie Thomsen | Independent Director | Intent to Sell (Form 144) | -1,396 | $377.94 |
| 2026-07-21 | Andy Bessette | Executive Vice President | Open Market Disposition | -3,000 | $368.09–368.87 |
| 2026-07-21 | William Heyman | Vice Chairperson | Intent to Sell (Form 144) | -4,701 | $370.00 |
| 2026-07-21 | David Rowland | Executive VP & Co-Chief Investment Officer | Derivative Exercise and Sale | -5,000 | $132.58–371.69 |
| 2026-07-21 | Paul Munson | Senior VP of Finance, Corporate Controller & Principal Accounting Officer | Derivative Exercise and Sale | -1,525 | $126.18–369.91 |
| 2026-07-20 | William Heyman | Vice Chairperson | Intent to Sell (Form 144) | -8,000 | $366.68 |
| 2026-07-20 | Mojgan Lefebvre | Executive VP, Chief Technology & Operations Officer | Derivative Exercise and Sale | -16,313 | $132.58–368.41 |
| 2026-07-20 | Michael Klein | Executive VP & President of Personal Insurance | Derivative Exercise and Sale | -6,000 | $139.83–366.12 |
| 2026-07-20 | Daniel Frey | Chief Financial Officer | Derivative Exercise and Sale | -14,037 | $139.83–368.53 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:05:45 · For reference only, not investment advice and not tailored to your situation.